BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21509873)

  • 1. MRI for staging lymphoma: whole-body or less?
    Kwee TC; Akkerman EM; Fijnheer R; Kersten MJ; Zsíros J; Ludwig I; Bierings MB; Vermoolen MA; van Leeuwen MS; Stoker J; Nievelstein RA
    J Magn Reson Imaging; 2011 May; 33(5):1144-50. PubMed ID: 21509873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography.
    Kwee TC; van Ufford HM; Beek FJ; Takahara T; Uiterwaal CS; Bierings MB; Ludwig I; Fijnheer R; Nievelstein RA
    Invest Radiol; 2009 Oct; 44(10):683-90. PubMed ID: 19724232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: comparison with CT in a prospective multicenter study.
    Kwee TC; Vermoolen MA; Akkerman EA; Kersten MJ; Fijnheer R; Ludwig I; Beek FJ; van Leeuwen MS; Bierings MB; Bruin MC; Zsíros J; Quarles van Ufford HM; de Klerk JM; Adam J; Stoker J; Uiterwaal CS; Nievelstein RA
    J Magn Reson Imaging; 2014 Jul; 40(1):26-36. PubMed ID: 24307538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of whole body MRI and diffusion-weighted MRI in detecting intranodal lesions in patients with lymphoma].
    Li Z; Hu DY; Xia LM; Feng DY; Peng L; Wang CY; Chu Q
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):695-8. PubMed ID: 19173913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
    Ribrag V; Vanel D; Leboulleux S; Lumbroso J; Couanet D; Bonniaud G; Aupérin A; Masson F; Bosq J; Edeline V; Fermé C; Pigneur F; Schlumberger M
    Eur J Radiol; 2008 May; 66(2):325-31. PubMed ID: 17651934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy.
    Adams HJ; Kwee TC; Lokhorst HM; Westerweel PE; Fijnheer R; Kersten MJ; Verkooijen HM; Stoker J; Nievelstein RA
    J Magn Reson Imaging; 2014 Jun; 39(6):1394-400. PubMed ID: 24310955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging techniques: whole-body screening and staging with MRI.
    Lauenstein TC; Semelka RC
    J Magn Reson Imaging; 2006 Sep; 24(3):489-98. PubMed ID: 16888774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns.
    Weininger M; Lauterbach B; Knop S; Pabst T; Kenn W; Hahn D; Beissert M
    Eur J Radiol; 2009 Feb; 69(2):339-45. PubMed ID: 18096344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of malignant lymphoma.
    Vermoolen MA; Kersten MJ; Fijnheer R; van Leeuwen MS; Kwee TC; Nievelstein RA
    Expert Rev Hematol; 2011 Apr; 4(2):161-71. PubMed ID: 21495926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI for the staging and follow-up of patients with metastasis.
    Schmidt GP; Reiser MF; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning.
    Dirix P; Vandecaveye V; De Keyzer F; Op de Beeck K; Poorten VV; Delaere P; Verbeken E; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):761-6. PubMed ID: 19540069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.
    Seemann MD; Meisetschlaeger G; Gaa J; Rummeny EJ
    Eur J Med Res; 2006 Feb; 11(2):58-65. PubMed ID: 16504962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
    Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
    Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT).
    Frericks BB; Meyer BC; Martus P; Wendt M; Wolf KJ; Wacker F
    J Magn Reson Imaging; 2008 Mar; 27(3):538-45. PubMed ID: 18224677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study.
    Schmidt GP; Wintersperger B; Graser A; Baur-Melnyk A; Reiser MF; Schoenberg SO
    Invest Radiol; 2007 Jun; 42(6):449-59. PubMed ID: 17507818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body MRI vs. CT for staging lymphoma: patient experience.
    Adams HJ; Kwee TC; Vermoolen MA; Ludwig I; Bierings MB; Nievelstein RA
    Eur J Radiol; 2014 Jan; 83(1):163-6. PubMed ID: 24211036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of whole-body MRI and CT for the staging of lymphoma.
    Brennan DD; Gleeson T; Coate LE; Cronin C; Carney D; Eustace SJ
    AJR Am J Roentgenol; 2005 Sep; 185(3):711-6. PubMed ID: 16120924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone marrow scintigraphy and magnetic resonance tomography in malignant lymphomas: comparison with histologic results].
    Linden A; Zankovich R; Theissen P; Schauerte G; Diehl V; Schicha H
    Nuklearmedizin; 1989 Oct; 28(5):166-71. PubMed ID: 2813080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.